Abstract
Novel glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R) dual agonists are reported to have improved efficacy over GLP-1R mono-ago......
小提示:本篇文献需要登录阅读全文,点击跳转登录